2017 Congress of International Society for Pharmacoeconomics and Outcomes Research

Країна: Англія

Місто: Glasgow

Тези до: 27.06.2017

Дати: 04.11.17 — 08.11.17

Е-мейл Оргкомітету: info@ispor.org

Організатори: International Society for Pharmacoeconomics and Outcomes Research


Why Submit to ISPOR 2017 Glasgow?

    Audience: Approximately 5,000 congress attendees from the global HEOR community.
    Advance the Science: Contribute your research; share your knowledge and ideas.
    Extend Your Research Impact: The promotion and dissemination of ISPOR congress content, coupled with the ISPOR attendee profile and global recognition, broadens the reach and impact of your research.
    Career Development Opportunities and Recognition: Abstract publication and research excellence award finalist eligibility. All accepted research abstracts are published in Value in Health.

Short Course Program
Saturday, 4 November 2017 - Full Day

    Introduction to Health Economic/Pharmacoeconomic Evaluations

Saturday, 4 November 2017 - Morning Session

    Introduction to the Design & Analysis of Observational Studies of Treatment Effects Using Retrospective Data Sources
    Introduction to Patient-Reported Outcomes Assessment
    Introduction to Modeling
    Development of Conceptual Models
    Cost-Effectiveness Analysis Alongside Clinical Trials
    Elements of Pharmaceutical / Biotech Pricing
    Conjoint Analysis – Theory & Methods

Saturday, 4 November 2017 - Afternoon Session

    Introduction to Health Technology Assessment
    Meta-Analysis & Systematic Literature Review
    Statistical Methods for Pharmacoeconomics & Outcomes Research
    Use of Propensity Scores in Observational Studies of Treatment Effects
    Collecting Health-State Utility Estimates for Economic Models in Clinical Studies
    Pharmacoeconomic Modeling – Applications
    NEW! Introduction to Designing Authentic and Impactful Patient-Centered Outcomes Research

Sunday, 5 November 2017 - Full Day

    Bayesian Analysis – Overview and Applications

Sunday, 5 November 2017 - Morning Session

    NEW! US Payers – an Introduction to Their Structures, Evidence Needs, and Decision-Making Process
    Using DICE Simulation for Health Economic Analyses
    Use of Instrumental Variables in Observational Studies of Treatment Effects
    Transferability and Relevance of Cost-Effectiveness Data Between Countries
    NEW! Mapping to Estimate Utility Values from Non-Preference Based Outcome Measures
    Budget Impact Analysis I: A 6-Step Approach
    Risk-Sharing / Performance-Based Arrangements for Drugs and Other Medical Products
    Understanding Survival Modeling with Application to HTA

Sunday, 5 November 2017 - Afternoon Session

    Budget Impact Analysis II: Applications & Design Issues
    Advanced Methods for Addressing Selection Bias in Real-World Effectiveness and Cost-Effectiveness Studies
    Introduction to the Economic Analysis of Diagnostics
    Network Meta-Analysis in Relative Effectiveness Research
    Risk-Sharing/Performance-Based Arrangements in Central & Eastern Europe: Implementation of Managed Entry Agreements
    Adjusting for Time-Dependent Confounding and Treatment Switching Bias in Observational Studies and Clinical Trials: Purpose, Methods, Good Practices and Acceptance in HTA
    Reimbursement Systems for Pharmaceuticals in Europe
    Using Multi-Criteria Decision Analysis in Health Care Decision Making: Approaches & Applications



Веб-сторінка конференції: https://www.ispor.org/Event/Index/2017Glasgow